Flowserve director receives restricted stock grant
Okray Thomas B reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Okray Thomas B reported acquisition or exercise transactions in this Form 4 filing.
Flowserve Corp director Thomas B. Okray received a stock-based compensation grant, increasing his direct holdings. He was awarded 2,573 shares of Flowserve common stock at a reference price of $67.99 per share as a restricted stock grant under the Flowserve Long-Term Incentive Plan. Following this award, he directly holds 13,335 common shares. The restricted shares vest on the earlier of May 14, 2027 or the date of Flowserve’s 2027 annual meeting of shareholders, meaning full ownership is tied to continued board service through that date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,573 | $67.99 | $175K |
Footnotes (1)
- F1. Represents the annual restricted stock grant for the director under the Flowserve Long-Term Incentive Plan. The shares vest on the earlier of May 14, 2027 or the date of Flowserve's 2027 annual meeting of shareholders.
Key Figures
Key Terms
restricted stock grant financial
Flowserve Long-Term Incentive Plan financial
vest financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Flowserve (FLS) director Thomas B. Okray report on this Form 4?
Is the Okray Form 4 transaction for Flowserve (FLS) a buy or a grant?
What plan governs the restricted stock grant reported by Flowserve (FLS) director Okray?
AI-generated analysis. How Rhea-AI works. Not financial advice.